NCT05065359 - Multiple-Ascending Dose in Japanese Patients Bridging Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

March 30, 2022

Study Completion Date

March 30, 2022

Conditions

Healthy

Interventions

DRUG

Rodatristat Ethyl 300 mg BID

Tablets, oral, 300 mg, BID 14 days

DRUG

Rodatristat Ethyl 600 mg BID

Tablets, oral, 600 mg, BID 14 days

DRUG

Placebo

Tablets, oral, 0 mg, BID for 14 days

Trial Locations (1)

California Clinical Trials Medical Group (CCTMG), Glendale